WGCU: Clinical research center in Southwest Florida works to help improve brain health

WGCU | By Bryant Monteilh Published December 18, 2023 at 7:06 PM EST In Florida, one out of five residents is older than 65 and they have become one of the fastest growing in the state. Florida also has one of the fastest rising rates of Alzheimer’s dementia — 580,000 Floridians aged 65 and older are living […]

Read more »

Georgia couple take part in clinical trials in hopes of slowing the progression of Alzheimer’s

/

Atlanta News First- By Sawyer Buccy Published: Nov. 29, 2023 at 4:51 PM EST|Updated: 15 hours ago ATLANTA, Ga. (Atlanta News First) – You probably know someone whose life has been impacted in one way or another by Alzheimer’s. Some people are fighting to find ways to slow the progression of the disease through clinical trials. One Georgia […]

Read more »

Opinion Column in Orlando Sentinel: Research funds are vital in fight against Alzheimer’s | Commentary

By JOANN GREER November 18, 2023 at 5:30 a.m. My husband and I know first-hand the toll that Alzheimer’s Disease has as we have cared for a mom and stepfather who lived with Alzheimer’s Disease before they passed away. With it being National Alzheimer’s Disease Awareness Month and National Family Caregiver’s Month, we would like to […]

Read more »

Free health screenings for National Alzheimer’s Disease Awareness Month

POSTED ON NOVEMBER 10, 2023 by WMNF BY COLLEEN COLE More than 580,000 individuals in Florida are currently living with Alzheimer’s disease. Next Thursday, individuals 50 years and older are going to be provided free health screenings in recognition of National Alzheimer’s Disease Awareness Month at a Senior Brain Health Expo. According to a press release from […]

Read more »

Couple gets involved in Florida Alzheimer’s research trials

/

His wife, Joann, is a retired nurse and also knew that research was going to be the way forward for them and for future generations.   To find out about studies near you, go to K2Med.com or Fastertrials.org to find sites around the US.

Read more »

Free memory testing at Brain Matters Research in Delray Beach

/

‘Coming in and just answer some questions, and seeing if there’s something that needs to be investigated,’ By: Victor Jorges WPTV5 DELRAY BEACH, Fla. — A Palm Beach County research organization is helping people with their memory for free. Brain Matters Research in Delray Beach is hosting free memory screenings on Tuesday and Wednesday from 9 […]

Read more »

Memory Machine drives into town to promote brain health awareness on Oct. 6

Brain Matters Research and Neuropsychiatric Research Center of Southwest Florida take Alzheimer’s Disease clinical research on the road By Staff | Oct 4, 2023 Brain Matters Research and Neuropsychiatric Research Center of Southwest Florida will be driving clinical research into the community as they introduce the Memory Machine to Fort Myers. The new Memory Machine will allow […]

Read more »

People with Down syndrome deserve access to Alzheimer’s treatment

/

People with Down syndrome helped scientists pave the way for Alzheimer’s drugs but are now left out of the treatment. By Hampus Hillerstrom and Jo Ann Simons  The clinical trials for new Alzheimer’s disease treatment drugs — which researchers believe will slow the course of the disease over time — offer hope to thousands of […]

Read more »

Sarasota researchers host memory screening for Alzheimer’s

By Sydney RoellSARASOTA COUNTY,  Fla. (SNN) — In honor of Sept. 21 being World Alzheimer’s Day, a group of Sarasota researchers hosted a free bilingual memory screening. Intercoastal Medical Group Neurology and Research Clinic offered their free, confidential memory screening in English and Spanish on Thursday from 8 a.m. to 3 p.m. at Robert L. Taylor […]

Read more »

A healthy diet may lower dementia risk — even if you start late

/

By Janet Lee – Washington Post Consumer Reports has no financial relationship with any advertisers on this site. Doing puzzles, playing memory-boosting games, taking classes and reading are activities that we often turn to for help keeping our brains sharp. But research is showing that what you eat, how often you exercise and the type of exercise you do […]

Read more »

Sarasota researchers plan free, bilingual memory screening on World Alzheimer’s Day

/

Free, bilingual screening on World Alzheimer’s Day Intercoastal Medical Group Neurology and Research Clinic will hold a free, bilingual?memory?screening event on World Alzheimer’s Day on Sept. 21 from 8 a.m. to 3 p.m. at Robert L. Taylor Community Complex, 1845 John Rivers St., in Sarasota. The goal of the confidential? screening in English and Spanish […]

Read more »

Aumentan los casos de Alzheimer en el Valle de Texas

Jessica Cantu from GAP-Net site El Faro Health and Therapeutics was at the Alzheimer’s Association’s International Conference (AAIC) in Amsterdam and spoke about the creation of the site in Starr County, Texas. En el condado Starr, casi uno en cada cuatro adultos de 65 años de edad en adelante fueron diagnosticados con Alzheimer en el […]

Read more »

Next On Medicare’s To Do List For Alzheimer’s: Coverage Of PET Scans And Genetic Testing

/

By Cathy Kelly Medicare policymakers have felt that without an effective approved treatment, coverage of amyloid PET scans and APOE4 genetic tests was not warranted. But that is changing. There is more to Medicare coverage for Alzheimer’s treatment than Leqembi, Eisai Co., Ltd. and Biogen, Inc.’s newly-approved amyloid-targeting monoclonal antibody. Now the program also is considering amending restrictive coverage […]

Read more »

Broader Medicare Coverage For Leqembi Begins As CMS-Backed Registry Opens For Business

/

By Cathy Kelly There is no fee to participate, and entries to the registry must be made at baseline and then every six months for up to two years. The Centers for Medicare and Medicaid Services is sticking with its plan to provide broader Medicare coverage for Eisai Co., Ltd. and Biogen, Inc.’s Leqembi for Alzheimer’s – now that […]

Read more »

The Numbers Tell The Story: Alzheimer’s Disproportionate Impact On Black Americans

/

GAP Community Connector, Paula Atkinson, was a guest writer for the Orlando Times and explained why she and GAP are committed to advancing Alzheimer’s clinical research in Black and Brown communities. My grandmother was treated for Alzheimer’s disease, but never diagnosed with it. Why? She was toldby her doctor that it would take too long […]

Read more »

Kerwin Medical Center seeks to slow the progression of Alzheimer’s disease

GAP-Net Site Kerwin Medical Center was featured in Community Impact on the rate of Alzheimer’s disease in Hispanic communities, and how they can help. As part of a nationwide study, Kerwin Medical Center is testing the efficacy of Aducanumab, a drug that helps a type of plaque in the brain and slows memory impairment caused […]

Read more »

New research Study Examines Potential Alzheimer’s Treatment To Help Address “Silent Epidemic” In The Orlando Black Community

GAP-Net Site K2 Medical Research was featured in the Orlando Times speaking about the rate of Alzheimer’s in the black community, and studies they have that can help. ORLANDO – For the 580,000 Floridians who are living with Alzheimer’s disease, or for the state’s 1.1 million citizens who who serve as unpaid Alzheimer’s caregivers, one […]

Read more »

Drugmaker Warns US Data Rules Threaten Access to Alzheimer’s Treatment

/

GAP President John Dwyer was quoted in the Financial Times talking about how the CMS decision will limit patient access to possible life saving Alzheimer’s treatments. Eisai has warned that mandatory data collection by US health authorities could restrictpatient access to the Japanese drugmaker’s new Alzheimer’s treatment. The company said a decision by Centers for […]

Read more »

CMS Announces Alzheimer’s Drug Coverage Policy, but ‘the evil is in the details,’ Experts say

/

GAP President John Dwyer was featured in McKnights Senior Living on the CMS decision to support only traditionally FDA-approved drugs. A Thursday announcement by the Centers for Medicare & Medicaid Services regarding coverage of Alzheimer’s drugs is being met with skepticism by some industry advocates who say that “the devil is in the details.” CMS […]

Read more »

Medicare Outlines Plan to Expand Coverage for Costly New Alzheimer’s Drugs

GAP President John Dwyer was quoted in the Washington Post on the CMS decision. The Centers for Medicare and Medicaid Services said it would cover a class of Alzheimer’s drugs that includes Leqembi if the medicines get traditional approval by drug regulators. (Eisai/Reuters) Medicare officials outlined plans Thursday to broadly cover a new class of […]

Read more »

Black, Hispanic volunteers sought for Alzheimer’s study in Albany

GAP-Net Site The Alzheimer’s Disease Research Center of Albany is looking for volunteers for their research studies. ALBANY — The Alzheimer’s Disease  Research Center of Albany is looking for volunteers for an Alzheimer’s clinical study, putting an emphasis on the recruitment of people of color.  While people from underrepresented communities — including those who are […]

Read more »

GAP President on Donanemab Trial Results: Alzheimer’s Patients and Their Doctors May Have Another Disease-Modifying Therapy to Address this Disease

WASHINGTON, DC, May 3, 2023 — Following the announcement of Eli Lilly’s Phase 3 results on a study evaluating donanemab for the treatment of Alzheimer’s disease, Global Alzheimer’s Platform Foundation® (GAP) President John Dwyer said, “Today’s announcement is good news. After waiting nearly 20 years for a new treatment for Alzheimer’s, Alzheimer’s patients and their doctors […]

Read more »

House Energy & Commerce Subcommittee Tells CMS: Fix Alzheimer’s Drug Coverage

House Energy & Commerce Subcommittee Tells CMS: Fix Alzheimer’s Drug Coverage WASHINGTON, DC (April 27, 2023) – The Global Alzheimer’s Platform Foundation®(GAP) President John Dwyer commends the strong, bipartisan leadership shown yesterday by U.S. Reps. Brett Guthrie (R-KY) and Anna Eshoo (D-CA) for admonishing the U.S. Centers for Medicare and Medicaid Services (CMS) administrator Chiquita […]

Read more »
To top